Name

BCD

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for BCD

Name

Alternate Names

Actinomycin
Actinomycin AIV
Actinomycin C1
Actinomycin D
Actinomycin I1
Actinomycin IV
Actinomycindioic D-acid dilactone
Cosmegen
Dactino-mycin D
Meractinomycin
Oncostatin K

Abbreviations

ACD
ACT
ACT-D
ACTD
Acto-D
AD
Dact

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

003053
3053

Primary Site

Ewing's sarcoma
rhabdomyosarcoma
testicular cancer
Wilm's tumor

Histology

None

Remarks

FDA approved use on Ewing's sarcoma, rhabdomyosarcoma, gestational trophoblastic neoplasms, testicular carcinoma, Wilm's tumor (antitumor antibiotic)

Coding

This drug should be coded

Name

Alternate Names

Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719

Abbreviations

CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

026271
26271

Primary Site

Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor

Histology

None

Remarks

An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent

Coding

This drug should be coded

Name

Alternate Names

Blenoxane
Bleo
Bleo-Cell
Bleo-S
Bleomycin for Injection
Bleomycin sulfate
Oil Bleo

Abbreviations

BLE
BLEO
BLM

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

125066

Primary Site

Squamous cell cancers

Histology

None

Remarks

FDA approved uses on squamous cell cervical cancer, head & neck cancer, Hodgkin's and non-Hodgkin's lymphoma, nasopharyngeal cancer, carcinoma, and testicular cancer.

Coding

This drug should be coded
Glossary